
|Slideshows|June 29, 2015
MS Research Roundup
Author(s)Mark L. Fuerst
Recent studies on MS are highlighted, including a possible new avenue for future therapies.
Advertisement
Some studies suggest that MS patients have begun to live longer lives over the last 40 to 50 years. New research suggests that MS patients do not live as long as those in the general population, but controlling comorbidities may help improve their survival. On the positive side, MS patients may have lower rates of vascular comorbidities, including hypertension, diabetes, and hyperlipidemia, than the general population, according to another study. And new research on the sex differences in MS may lead to new MS therapies.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup
2
FDA Clears Phase 2 Trial for Demyelinating Agent Lucid-MS in Progressive Multiple Sclerosis
3
Zoster Vaccine Shows Strong Effectiveness in Patients With Multiple Sclerosis
4
Voyager to Advance 2 Tau-Targeted Alzheimer Therapies Toward Key Clinical Milestones
5














